Exceptional diversity of KIR and HLA class I in Egypt
HLA · 2024
DOI: 10.1111/tan.15177 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Gonzalo Montero-Martin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Blood Center, Department of Pathology, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Multimorbidity, Receptors, KIR, North African People. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Genetically determined variation of killer cell immunoglobulin like receptors (KIR) and their HLA class I ligands affects multiple aspects of human health. Their extreme diversity is generated through complex interplay of natural selection for pathogen resistance and reproductive health, combined with demographic structure and dispersal. Despite significant importance to multiple health conditions of differential effect across populations, the nature and extent of immunogenetic diversity is under‐studied for many geographic regions. Here, we describe the first high‐resolution analysis of KIR and HLA class I combinatorial diversity in Northern Africa. Analysis of 125 healthy unrelated individuals from Cairo in Egypt yielded 186 KIR alleles arranged in 146 distinct centromeric and 79 distinct telomeric haplotypes. The most frequent haplotypes observed were KIR‐A, encoding two inhibitory receptors specific for HLA‐C, two that are specific for HLA‐A and ‐B, and no activating receptors. Together with 141 alleles of HLA class I, 75 of which encode a KIR ligand, we identified a mean of six distinct interacting pairs of inhibitory KIR and HLA allotypes per individual. We additionally characterize 16 KIR alleles newly identified in the study population. Our findings place Egyptians as one of the most highly diverse populations worldwide, with important implications for transplant matching and studies of immune‐mediated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stanford Blood Center, Department of Pathology, Stanford University, Stanford, California, USA.
- Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado, USA.
- Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
- Department of Pathology, University of Chicago Medicine, Chicago, Illinois, USA.
- BMT lab unit, Clinical Pathology Dept., National Cancer Institute, Cairo University, Cairo, Egypt.
- Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
ORCID-Profile: Maneesh K Misra, Wesley M Marin, Paul J Norman
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Montero-Martin, G., Kichula, K. M., Misra, M. K., de Brito Vargas, L., Marin, W. M., Hollenbach, J. A., Fernández-Viña, M. A., Elfishawi, S., & Norman, P. J. (2024). Exceptional diversity of KIR and HLA class I in Egypt. HLA. https://doi.org/10.1111/tan.15177
Vancouver
Montero-Martin G, Kichula KM, Misra MK, de Brito Vargas L, Marin WM, Hollenbach JA, et al. Exceptional diversity of KIR and HLA class I in Egypt. HLA. 2024. doi:10.1111/tan.15177
BibTeX
@article{MonteroMartin2024,
author = {Montero-Martin, Gonzalo and Kichula, Katherine M and Misra, Maneesh K and de Brito Vargas, Luciana and Marin, Wesley M and Hollenbach, Jill A and Fernández-Viña, Marcelo A and Elfishawi, Sally and Norman, Paul J},
title = {Exceptional diversity of KIR and HLA class I in Egypt},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15177}
}
EUVIMED